Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [03/20/2026 12:42 PDT] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($18.93) From $18.93 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/19/2026 14:55 PDT] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($17.53) From $17.53 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/19/2026 14:55 PDT] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($17.4) From $17.4 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/19/2026 14:55 PDT] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($17.45) From $17.45 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/16/2026 07:10 PDT] ETON Expected to Trade Up After Bullish Patterns Develop
• [03/12/2026 15:33 PDT] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($17.4) From $17.4 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/11/2026 07:13 PDT] ETON Expected to Trade Up After Bullish Patterns Develop
• [03/11/2026 06:41 PDT] ETON Expected to Trade Up Short Term
• [03/05/2026 07:25 PST] ETON Expected to Trade Up After Bullish Patterns Develop
• [03/04/2026 06:44 PST] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [03/03/2026 06:38 PST] ETON Expected to Trade Up Short Term
• [02/25/2026 14:55 PST] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($17.07) From $17.07 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/24/2026 10:29 PST] Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Up By 100% ($16.79) From $16.79 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/17/2026 07:37 PST] ETON Expected to Trade Up After Bullish Patterns Develop
• [02/13/2026 07:43 PST] ETON Expected to Trade Up Short Term
• [02/05/2026 07:29 PST] ETON Expected to Trade Down Short Term